Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Wilms Tumor 1 Sarcoma 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced Head and Neck Carcinoma 1 Leukemia 1 Kidney Neoplasms 1 Fanconi Anemia 1 Dendritic Cell Sarcoma, Interdigitating 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1

Interventions

AZD 6244 9 trametinib 3 mirdametinib 3 Lovastatin 3 Sirolimus 2 Inhalation 2 Everolimus 2 Acetylcysteine 2 tipifarnib 1 thymoglobulin 1 pirfenidone 1 peginterferon alfa-2b 1 omipalisib 1 fludarabine 1 cediranib 1 binimetinib 1 Vitamin D 1 Vincristine 1 Vinblastine 1 Temozolomide 1 Sunitinib 1 Saline Solution 1 Rituximab 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 N-monoacetylcystine 1 Methotrexate 1 Melphalan 1 Levetiracetam 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neurofibromatosis 1 × Dietary Supplements × Clear all

NCT01968590 2022-05-25

VitDBoneNF1

University of Utah

Phase 2 Terminated

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡